High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker

KUMTEPE, Yakup; HALICI, Zekai; SENGUL, Ozlem; Kunak, Celalettin; BAYIR, Yasin; Kilic, Nergiz; ÇADIRCI, Elif; PULUR, Alparslan; BAYRAKTUTAN, Zafer

doi:10.1186/2047-783x-18-18

High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker

Atıf İçin Kopyala

KUMTEPE Y., HALICI Z., SENGUL O., Kunak C. S., BAYIR Y., Kilic N., ...Daha Fazla

EUROPEAN JOURNAL OF MEDICAL RESEARCH, cilt.18, 2013 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18
Basım Tarihi: 2013
Doi Numarası: 10.1186/2047-783x-18-18
Dergi Adı: EUROPEAN JOURNAL OF MEDICAL RESEARCH
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Atatürk Üniversitesi Adresli: Evet

Özet

Background: Human HIV-1 TAT interactive protein 2 (HTATIP2/TIP30) is an evolutionarily conserved gene that is expressed ubiquitously in human tissues and some tumor tissues. This protein has been found to be associated with some gynecological cancers; as such, this study aimed to investigate blood HTATIP2/TIP30 levels in patients with ovarian cancer.